| α-SMA | α-smooth muscle actin |
| α-Galcer | α-Galactosylceramide |
| AhR | aryl hydrocarbon receptor |
| AILD | autoimmune liver diseases |
| ASK1 | apoptosis signal-regulating kinase 1 |
| BAFF | B-cell activating factor |
| BALF | bronchoalveolar lavage fluid |
| BDL | Bile duct ligation |
| Bregs | regulatory B cells |
| CCl4 | carbon tetrachloride |
| CCL2 | C-C motif chemokine ligand 2 |
| CKD | chronic kidney disease |
| COPD | chronic obstructive pulmonary disease |
| DC | Dendritic cell |
| DILI | drug-induced liver injury |
| ECM | extracellular matrix |
| FGF-9 | fibroblast growth factor 9 |
| GVHD | graft-versus-host disease |
| NASH | nonalcoholic steatohepatitis |
| HBV | hepatitis B virus |
| HCV | hepatitis C virus |
| HMF | hepatic myofibroblast |
| HSCs | hepatic stellate cells |
| ICOS | inducible co-stimulator |
| ILCs | innate lymphoid cells |
| iNKT cells | invariant natural killer T cells |
| IPF | idiopathic pulmonary fibrosis |
| JAK | Janus kinase |
| MAIT cells | mucosal-associated invariant T cells |
| MAPK | mitogen-activated protein kinase |
| MMPs | matrix metalloproteinases |
| mTOR | mammalian target of rapamycin |
| NAFLD | nonalcoholic fatty liver disease |
| NASH | nonalcoholic steatohepatitis |
| NE | neutrophil elastase |
| NK cells | natural killer cells |
| NKT cells | natural killer T cells |
| PBC | primary biliary cholangitis |
| PDGF | platelet-derived growth factor |
| PTECs | proximal tubular epithelial cells |
| SSc | systemic sclerosis |
| STAT | signal transducers and activators of transcription |
| Tfh cells | T follicular helper cells |
| TGF-β | transforming growth factor-β |
| TRAIL | TNF-related apoptosis-inducing ligand |
| Tregs | regulatory T cells |
| UUO | unilateral ureteral obstruction |